Terms: = Skin cancer AND PALB2, ENSG00000083093, 79728
15 results:
1. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
[TBL] [Abstract] [Full Text] [Related]
2. Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and palb2 in a Tumor-Only Genomic Testing Program.
Bychkovsky BL; Li T; Sotelo J; Tayob N; Mercado J; Gomy I; Chittenden A; Kane S; Stokes S; Hughes ME; Kim JS; Umeton R; Awad MM; Konstantinopoulos PA; Yurgelun MB; Wolpin BM; Taplin ME; Newmark RE; Johnson BE; Lindeman NI; MacConaill LE; Garber JE; Lin NU
Clin Cancer Res; 2022 Jun; 28(11):2349-2360. PubMed ID: 35363308
[TBL] [Abstract] [Full Text] [Related]
3. Mutational landscape in Uveal Melanoma.
Mastronikolis S; Adamopoulou M; Papouliakos S; Manoli A; Katsinis S; Makri O; Monastirioti AE; Tsiambas E; Georgakopoulos C
J BUON; 2021; 26(4):1194-1197. PubMed ID: 34564968
[TBL] [Abstract] [Full Text] [Related]
4. Atypical choroidal nevus in a subject with a germline palb2 pathogenic variant.
Grosel TW; Karl M; Pilarski RT; Davidorf FH; Abdel-Rahman MH; Cebulla CM
Fam Cancer; 2022 Jan; 21(1):1-5. PubMed ID: 33403473
[TBL] [Abstract] [Full Text] [Related]
5. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract] [Full Text] [Related]
6. Missense palb2 germline variant disrupts nuclear localization of palb2 in a patient with breast cancer.
Toh MR; Low CE; Chong ST; Chan SH; Ishak NDB; Courtney E; Kolinjivadi AM; Rodrigue A; Masson JY; Ngeow J
Fam Cancer; 2020 Apr; 19(2):123-131. PubMed ID: 32048105
[TBL] [Abstract] [Full Text] [Related]
7. Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility.
Cho HG; Kuo KY; Li S; Bailey I; Aasi S; Chang ALS; Oro AE; Tang JY; Sarin KY
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089731
[TBL] [Abstract] [Full Text] [Related]
8. Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.
Trego KS; Groesser T; Davalos AR; Parplys AC; Zhao W; Nelson MR; Hlaing A; Shih B; Rydberg B; Pluth JM; Tsai MS; Hoeijmakers JHJ; Sung P; Wiese C; Campisi J; Cooper PK
Mol Cell; 2016 Feb; 61(4):535-546. PubMed ID: 26833090
[TBL] [Abstract] [Full Text] [Related]
9. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of palb2 as a candidate melanoma susceptibility gene.
Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
[TBL] [Abstract] [Full Text] [Related]
11. Familial pancreatic cancer: genetic advances.
Rustgi AK
Genes Dev; 2014 Jan; 28(1):1-7. PubMed ID: 24395243
[TBL] [Abstract] [Full Text] [Related]
12. Familial pancreatic cancer--current knowledge.
Bartsch DK; Gress TM; Langer P
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):445-53. PubMed ID: 22664588
[TBL] [Abstract] [Full Text] [Related]
13. Lack of germline palb2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer.
Yang XR; Jessop L; Myers T; Amundadottir L; Pfeiffer RM; Wheeler W; Pike KM; Yuenger J; Burdett L; Yeager M; Chanock SJ; Tucker MA; Goldstein AM
Fam Cancer; 2011 Sep; 10(3):545-8. PubMed ID: 21614589
[TBL] [Abstract] [Full Text] [Related]
14. Mutation analysis of the palb2 cancer predisposition gene in familial melanoma.
Sabbaghian N; Kyle R; Hao A; Hogg D; Tischkowitz M
Fam Cancer; 2011 Jun; 10(2):315-7. PubMed ID: 21153565
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of palb2/FANCN-associated breast cancer families.
Tischkowitz M; Xia B; Sabbaghian N; Reis-Filho JS; Hamel N; Li G; van Beers EH; Li L; Khalil T; Quenneville LA; Omeroglu A; Poll A; Lepage P; Wong N; Nederlof PM; Ashworth A; Tonin PN; Narod SA; Livingston DM; Foulkes WD
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6788-93. PubMed ID: 17420451
[TBL] [Abstract] [Full Text] [Related]